Titlebook: Rare Disease Drug Development; Clinical, Scientific Raymond A. Huml Book 2021 The Editor(s) (if applicable) and The Author(s), under exclus

Arthur

书目名称Rare Disease Drug Development影响因子(影响力)




书目名称Rare Disease Drug Development影响因子(影响力)学科排名




书目名称Rare Disease Drug Development网络公开度




书目名称Rare Disease Drug Development网络公开度学科排名




书目名称Rare Disease Drug Development被引频次




书目名称Rare Disease Drug Development被引频次学科排名




书目名称Rare Disease Drug Development年度引用




书目名称Rare Disease Drug Development年度引用学科排名




书目名称Rare Disease Drug Development读者反馈




书目名称Rare Disease Drug Development读者反馈学科排名

尖

http://image.papertrans.cn/r/image/821231.jpg

ULCER

https://doi.org/10.1007/978-3-030-78605-2Rare disease; drug development; caregivers; orphan drug; disease-modifying treatments

CESS

抱狗不敢前

SENT

Introduction to Rare Diseases and Market Overview, and attempt to identify approaches to target those mechanisms to modify or perhaps cure the disease. Only a small number of rare diseases had approved therapies..Since then, there has been a marked increase in rare disease research funding and development effort, thanks to regulatory changes, multi

引导

Select Patient Narratives,nto the rare disease drug development and approval processes. Rare disease patients are the most appropriate individuals to consult in order to identify and rank the importance of the conditions that they face..This chapter will provide multiple views from persons/patients afflicted with different r

教义

A Mental Health Perspective,hapter will define terms related to mental health, provide an overview of the current state of mental health in the rare disease population, discuss the gaps and unmet needs that have been identified, and offer considerations for strategies and measures to address the gaps in providing mental health

增减字母法

陈旧